In Cancer Caregiving, a Passion for Learning is Vital

Article

Caregiving for a patient with cancer is an ongoing journey that also requires the caregiver to learn along the way. One couple discusses that process and more.

Cancer caregiving is more about taking a loved one to appointments or making sure they’re comfortable when they’re dealing with the effects of treatment. According to caregiver Rex Cowden, it’s about being interested in learning about your loved one’s disease and owning the experience with them. “You’re the one experiencing it,” he says, “but it’s our problem.”

Rex and his wife Janice recently sat down with CURE® to discuss what it was like to go through Janice’s two triple-negative breast cancer diagnoses, in 2011 and 2016, and how they worked as a team to learn about the disease, manage her treatment, and come through the other side to celebrate their 41st wedding anniversary.

Transcription:

Rex Cowden: I think learning, from a caregiver’s perspective, is so key. That you have to be interested in this. I can't imagine somebody going through cancer and having a spouse that is uninterested. They may be caring, you know, they may be doing their part as it relates to being a caregiver, but not fully understanding and learning as much as you possibly can.

Now, I'm fortunate because my learning came through her, because she researches, and so we were able to talk a lot about it at that time I was learning. Now, I forget half the stuff and I don't know some of the nuances. And she'll correct me on that. But it is difficult to figure it out.

My background is more engineering. So, I have this problem-solving mentality. So, I looked at it, you know, kind of like a problem. So, you're the one that's experienced it, but it's our problem. So what can I do to help you solve this problem?

I know that's not the right terminology. But that's basically it from an engineer's perspective.

Janice Cowden: I think to stay involved (is important too). One of the things that I've been very fortunate with is, he has attended every appointment with me, whether it's oncology labs, scans, he's even gone to conferences with me. I attend a lot of breast cancer and metastatic breast cancer conferences each year, and he's gone along with me to those which I think is a huge display of support for me because it does demonstrate to me that he is interested in learning.

And you know, at some of the conferences, they even have special sessions for caregivers, and he's learned a lot through those, too.

Related Videos
For patients with cancer, the ongoing chemotherapy shortage may cause some anxiety as they wonder how they will receive their drugs. However, measuring drugs “down to the minutiae of the milligrams” helped patients receive the drugs they needed, said Alison Tray. Tray is an advanced oncology certified nurse practitioner and current vice president of ambulatory operations at Rutgers Cancer Institute in New Jersey.  If patients are concerned about getting their cancer drugs, Tray noted that having “an open conversation” between patients and providers is key.  “As a provider and a nurse myself, having that conversation, that reassurance and sharing the information is a two-way conversation,” she said. “So just knowing that we're taking care of you, we're going to make sure that you receive the care that you need is the key takeaway.” In June 2023, many patients were unable to receive certain chemotherapy drugs, such as carboplatin and cisplatin because of an ongoing shortage. By October 2023, experts saw an improvement, although the “ongoing crisis” remained.  READ MORE: Patients With Lung Cancer Face Unmet Needs During Drug Shortages “We’re really proud of the work that we could do and achieve that through a critical drug shortage,” Tray said. “None of our patients missed a dose of chemotherapy and we were able to provide that for them.” Tray sat down with CURE® during the 49th Annual Oncology Nursing Society Annual Congress to discuss the ongoing chemo shortage and how patients and care teams approached these challenges. Transcript: Particularly at Hartford HealthCare, when we established this infrastructure, our goal was to make sure that every patient would get the treatment that they need and require, utilizing the data that we have from ASCO guidelines to ensure that we're getting the optimal high-quality standard of care in a timely fashion that we didn't have to delay therapies. So, we were able to do that by going down to the minutiae of the milligrams on hand, particularly when we had a lot of critical drug shortages. So it was really creating that process to really ensure that every patient would get the treatment that they needed. For more news on cancer updates, research and education, don’t forget to subscribe to CURE®’s newsletters here.
Dr. Andrea Apolo in an interview with CURE
Dr. Kim in an interview with CURE
Dr. Nguyen, from Stanford Health, in an interview with CURE
Dr. Barzi in an interview with CURE
Sue Friedman in an interview with CURE
Dr. Giles in an interview with CURE
Related Content